HST Global Inc. Additional Paid In Capital

Additional Paid In Capital of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Additional Paid In Capital growth rates and interactive chart.


Highlights and Quick Summary

  • Additional Paid In Capital for the quarter ending September 29, 2020 was $5.36 Million (a 0.0% decrease compared to previous quarter)
  • Year-over-year quarterly Additional Paid In Capital decreased by 0.0%
  • Annual Additional Paid In Capital for 2019 was $5.36 Million (a 121.5% increase from previous year)
  • Annual Additional Paid In Capital for 2018 was $2.42 Million (a 1.44% increase from previous year)
  • Annual Additional Paid In Capital for 2017 was $2.38 Million (a 0.0% decrease from previous year)
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Additional Paid In Capital of HST Global Inc.

Most recent Additional Paid In Capitalof HSTC including historical data for past 10 years.

Interactive Chart of Additional Paid In Capital of HST Global Inc.

HST Global Inc. Additional Paid In Capital for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $5.36 $5.36 $5.36
2019 $5.36 $5.3 $4.86 $2.38 $5.36
2018 $2.42 $2.38 $2.38 $2.38 $2.42
2017 $2.38 $2.38 $2.38 $2.38 $2.38
2016 $2.38 $2.38 $2.38 $2.38 $2.38
2015 $2.38 $2.38 $2.38 $2.38 $2.38
2014 $2.38 $2.38 $2.38 $2.38 $2.38
2013 $2.38 $2.38 $2.38 $2.38 $2.38
2012 $2.38 $2.42 $2.42 $2.42 $2.38
2011 $2.38 $2.26 $2.26 $0.0 $2.38
2010 $1.95 $1.95 $1.95 $1.84 $1.95
2009 $1.62 $1.62

Business Profile of HST Global Inc.

Sector: Healthcare
Industry: Biotechnology
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.